Biblio

Export 10 results:
Author Keyword Title [ Type(Desc)] Year
Filters: Author is Bjerke, Maria  [Clear All Filters]
Journal Article
E. Niemantsverdriet, Feyen, B. F. E., Le Bastard, N., Martin, J. - J., Goeman, J., De Deyn, P. Paul, Bjerke, M., and Engelborghs, S., Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort., J Alzheimers Dis, vol. 63, no. 1, pp. 373-381, 2018.
J. B. Toledo, Habes, M., Sotiras, A., Bjerke, M., Fan, Y., Weiner, M. W., Shaw, L. M., Davatzikos, C., and Trojanowski, J. Q., APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points., J Alzheimers Dis, vol. 69, no. 3, pp. 783-793, 2019.
E. Niemantsverdriet, Ottoy, J., Somers, C., De Roeck, E., Struyfs, H., Soetewey, F., Verhaeghe, J., Van den Bossche, T., Van Mossevelde, S., Goeman, J., De Deyn, P. Paul, Mariën, P., Versijpt, J., Sleegers, K., Van Broeckhoven, C., Wyffels, L., Albert, A., Ceyssens, S., Stroobants, S., Staelens, S., Bjerke, M., and Engelborghs, S., The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting., J Alzheimers Dis, vol. 60, no. 2, pp. 561-576, 2017.
M. Bjerke and Engelborghs, S., Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis., J Alzheimers Dis, vol. 62, no. 3, pp. 1199-1209, 2018.
M. Bjerke, Kern, S., Blennow, K., Zetterberg, H., Waern, M., Börjesson-Hanson, A., Östling, S., Kern, J., and Skoog, I., Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years., J Alzheimers Dis, vol. 49, no. 3, pp. 733-41, 2016.
J. Svensson, Blomqvist, M., Kettunen, P., Eckerström, C., Henricsson, M., Jonsson, M., Bjerke, M., Månsson, J. - E., and Wallin, A., Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of Dementia., J Alzheimers Dis, vol. 82, no. 2, pp. 781-790, 2021.
C. Somers, Struyfs, H., Goossens, J., Niemantsverdriet, E., Luyckx, J., De Roeck, N., De Roeck, E., De Vil, B., Cras, P., Martin, J. - J., De Deyn, P. - P., Bjerke, M., and Engelborghs, S., A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium., J Alzheimers Dis, vol. 54, no. 1, pp. 383-95, 2016.
J. Laton, Van Schependom, J., Goossens, J., Wiels, W., Sieben, A., De Deyn, P. Paul, Goeman, J., Streffer, J., van der Zee, J., Martin, J. - J., Van Broeckhoven, C., De Vos, M., Bjerke, M., Nagels, G., and Engelborghs, S., Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study., J Alzheimers Dis, 2022.
P. Johansson, Almqvist, E. G., Bjerke, M., Wallin, A., Johansson, J. - O., Andreasson, U., Blennow, K., Zetterberg, H., and Svensson, J., Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 59, no. 3, pp. 1017-1026, 2017.
E. Niemantsverdriet, Ribbens, A., Bastin, C., Benoit, F., Bergmans, B., Bier, J. - C., Bladt, R., Claes, L., De Deyn, P. Paul, Deryck, O., Hanseeuw, B., Ivanoiu, A., Lemper, J. - C., Mormont, E., Picard, G., Salmon, E., Segers, K., Sieben, A., Smeets, D., Struyfs, H., Thiery, E., Tournoy, J., Triau, E., Vanbinst, A. - M., Versijpt, J., Bjerke, M., and Engelborghs, S., A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER)., J Alzheimers Dis, vol. 63, no. 4, pp. 1509-1522, 2018.